drugset / Trial / NCT00679926
Kaletra and Viread in Antiretroviral Naïve Patients
NaSingle-groupOpen-labelTreatment
Summary
Once daily antiretroviral therapy with Viread (tenofovir DF, 300mg) plus Kaletra (LPV/r, 800mg/200mg) will be effective in suppressing and maintaining suppression of HIV RNA to \<50 copies/ml in antiretroviral naïve patients through 48 weeks of therapy.
Timeline
- Start
- 2008-05
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lopinavir | Other / unclassified | 800 mg | — |
| Subject | Ritonavir | Other / unclassified | 200 mg | — |
| Subject | Tenofovir disoproxil fumarate | Small molecule | 300 mg | — |